Fabrication of a vascularized bioartificial pancreas using macroencapsulation of stem cell-derived pancreatic islet cells for the treatment of type 1 Diabetes.

使用干细胞来源的胰岛细胞的大封装制造血管化生物人工胰腺，用于治疗 1 型糖尿病。

• 批准号: 437123
• 负责人: Brassard Jonathan
• 金额: $ 10.93万
• 依托单位: McGill University
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-11-01 至 2023-11-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=437123&lang=en
• 关键词: Biomaterials; Biomedical Device; Diabetes; Pancreatic Islets; Stem Cells; Transplantation

Type 1 diabetes affects more than 300 000 Canadians and its impact continues to rise in Canada and the world. Transplantation of pancreatic islets, the tissue regulating insulin and blood sugar, is a promising strategy to treat diabetic patients because i

1型糖尿病影响着30多万加拿大人，其影响在加拿大和世界上继续上升。胰岛是调节胰岛素和血糖的组织，移植胰岛是治疗糖尿病患者的一种有前途的策略，因为它